IL6 and COVID-19: As a result of this, the elevated levels of IL-6 observed in cancer patients and survivors can exacerbate the effect of a potential COVID-19-mediated cytokine storm in infected patients also through IL-6, which can lead to increased injury in both lung (58) and myocardial tissue (59).